• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Petco Health + Wellness Company, Inc. Reports Second Quarter Earnings

    8/24/23 7:00:00 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary
    Get the next $WOOF alert in real time by email

    Q2 2023 Operating Results

    • Comparable sales grew 3.2 percent year-over-year and 7.0 percent on a two-year basis, resulting in the 19th consecutive quarter of comparable sales growth
    • Net revenue of $1.53 billion increased 3.4 percent year-over-year
    • Net loss of $14.6 million, or $(0.05) per share compared to net income of $13.5 million, or $0.05 per share in the prior year
    • Adjusted Net Income1 decreased $27.2 million to $16.3 million
    • Adjusted EBITDA1 of $112.6 million compared to $133.5 million in the prior year
    • Adjusted Earnings Per Share1 of $0.06, compared to $0.16 per share in the prior year
    • Operating Cash Flow of $96.6 million compared to $42.6 million in the prior year
    • Free Cash Flow1 of $44.6 million, compared to $(27.7) million in the prior year

    SAN DIEGO, Aug. 24, 2023 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), a complete partner in pet health and wellness, today announced its second quarter 2023 financial results.    

    Petco (PRNewsFoto/Petco)

    In the second quarter of 2023, Petco delivered net revenue of $1.53 billion, up 3.4 percent versus prior year, driven by strength in the company's consumables business, up 6.8 percent versus prior year, and services and other business, up 30.6 percent versus prior year.  Second quarter revenue growth was partially offset by the company's supplies and companion animal business, down 9.4 percent versus prior year.  Net loss was $14.6 million or $(0.05) per share, driven in part by a $0.04 per share increase in interest expense year-over-year, compared to net income of $13.5 million or $0.05 per share in the prior year.  Adjusted Net Income1 was $16.3 million or $0.06 per share, compared to $43.5 million or $0.16 per share in the prior year.  Adjusted EBITDA1 was $112.6 million compared to $133.5 million in the prior year.

    "We continue to focus on execution through an uncertain environment, delivering our 19th consecutive quarter of comp sales growth, with ongoing strength in consumables and services, particularly in vet," said Petco CEO Ron Coughlin. "With discretionary spending continuing to be pressured, we're taking numerous strategic actions to strengthen our business, including initiatives to unlock a targeted $150 million in cost savings and productivity enhancements by the end of fiscal 2025. These actions, combined with the enduring competitive advantages of our differentiated offering, will position us even better to deliver sustainable and profitable growth for the long term."

    "In Q2, we delivered solid top line results and strong free cash flow," said Petco CFO Brian LaRose. "That said, the shift in consumer spending and pressures on our discretionary business mean we're revising our guidance accordingly. Looking ahead, we remain focused on debt paydown and cash flow, both of which will be supported by our productivity initiatives in addition to tightly controlled expense management." 

    In the second quarter of 2023, Petco paid down $25 million in principal on its term loan.  In August, the company further paid down an additional $15 million in principal on its term loan for a total of $75 million in principal payments year-to-date.  The company continues to target a total of $100 million in principal payments for fiscal 2023 and remains committed to strengthening its balance sheet through de-levering.

    The company also initiated a cost action plan in the quarter and estimates annualized gross run rate cost savings of $150 million by the end of fiscal 2025, from merchandise, supply chain, and G&A categories.  In year one, the company expects to achieve $40 million in savings. In Q2 2023, the company recorded $6 million in headcount reduction-related charges related to the cost action plan.

    (1)

    Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings Per Share ("Adjusted EPS"), and Free Cash Flow are non-GAAP financial measures. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

    Fiscal 2023 Guidance:

    The company is updating its fiscal 2023 guidance for Adjusted EBITDA, Adjusted EPS and Capital Expenditures and now expects:

    Metric*

    2023 Guidance

    Net Revenue

    $6.150 billion to $6.275 billion

    Adjusted EBITDA

    $460 million to $480 million

    Adjusted EPS

    $0.24 to $0.30

    Capital Expenditures

    $215 million to $225 million

     

    *Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent. Adjusted EPS guidance assumes approximately $145 to $155 million of interest expense, an estimated $43 to $53 million increase in interest expense year-over-year, a 26 percent tax rate, and a 269 million weighted average diluted share count. The Company estimates that the increase in interest expense will impact Adjusted EPS by approximately $0.12 to $0.15 per share.  Furthermore, Fiscal 2023 will be a 53-week year, leading to an incremental week of operations.  Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures and have not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission.

    Earnings Conference Call Webcast Information:

    Management will host an earnings conference call on August 24, 2023 at 8:00 AM Eastern Time to discuss the company's financial results.  The conference call will be accessible through a live webcast. Interested investors and other individuals can access the webcast, earnings release, earnings presentation, and infographic via the company's investor relations page at ir.petco.com. A replay of the webcast will be archived on the company's investor relations page through September 7, 2023 until approximately 5:00PM Eastern Time.

    About Petco, The Health + Wellness Co.:

    Founded in 1965, Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. We've consistently set new standards in pet care while delivering comprehensive pet wellness products, services and solutions, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 pet care centers across the U.S., Mexico and Puerto Rico, which offer merchandise, companion animals, grooming, training and a growing network of on-site veterinary hospitals and mobile veterinary clinics. Our complete pet health and wellness ecosystem is accessible through our pet care centers and digitally at petco.com and on the Petco app. In tandem with Petco Love, a life-changing organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we've helped find homes for nearly 7 million animals.

    Forward-Looking Statements:

    This earnings release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including statements regarding our fiscal year 2023 guidance. Such forward-looking statements can generally be identified by the use of forward-looking terms such as "believes," "expects," "may," "intends," "will," "shall," "should," "anticipates," "opportunity," "illustrative," or the negative thereof or other variations thereon or comparable terminology. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct or that any forward-looking results will occur or be realized. Nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. All forward-looking statements are based on current expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results or events to differ materially from the potential results or events discussed in the forward-looking statements, including, without limitation, those identified in this earnings release as well as the following: (i) increased competition (including from multi-channel retailers and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate, including inflation and prevailing interest rates; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a data privacy or security breach; (x) our ability to effectively manage or integrate strategic ventures, alliances or acquisitions and realize the anticipated benefits of such transactions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) business interruptions and other supply chain issues; (xiii) catastrophic events, political tensions, conflicts and wars (such as the ongoing conflict in Ukraine), health crises, and pandemics; (xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio; (xviii) constraints in the capital markets or our vendor credit terms; (xix) changes in our credit ratings; and (xx) the other risks, uncertainties and other factors identified under "Risk Factors" and elsewhere in Petco's Securities and Exchange Commission filings. The occurrence of any such factors could significantly alter the results set forth in these statements.

    Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any such forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except per share amounts)

    (Unaudited and subject to reclassification)























    13 Weeks Ended







    July 29,

    2023



    July 30,

    2022



    Percent

    Change



    Net sales



    $     1,530,734



    $     1,480,797



    3 %



    Cost of sales



    937,730



    886,320



    6 %



    Gross profit



    593,004



    594,477



    (0 %)



    Selling, general and administrative expenses



    568,967



    544,472



    4 %



    Operating income



    24,037



    50,005



    (52 %)



    Interest income



    (764)



    (137)



    458 %



    Interest expense



    37,493



    21,820



    72 %



    Loss on partial extinguishment of debt



    305



    —



    N/M



    Other non-operating (income) loss



    (1,795)



    10,259



    N/M



    (Loss) income before income taxes and income from

       equity method investees



    (11,202)



    18,063



    N/M



    Income tax expense



    6,732



    6,638



    1 %



    Income from equity method investees



    (3,328)



    (2,031)



    64 %



    Net (loss) income



    (14,606)



    13,456



    N/M



    Net loss attributable to noncontrolling interest



    —



    —



    N/M



    Net (loss) income attributable to Class A and B-1 common

       stockholders



    $        (14,606)



    $          13,456



    N/M



















    Net (loss) income per Class A and B-1 common share:















    Basic



    $            (0.05)



    $             0.05



    N/M



    Diluted



    $            (0.05)



    $             0.05



    N/M



















    Weighted average shares used in computing net (loss) income per Class A

       and B-1 common share:















    Basic



    267,163



    265,431



    1 %



    Diluted



    267,163



    265,835



    0 %



















     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONSOLIDATED BALANCE SHEETS

    (In thousands, except per share amounts)

    (Unaudited and subject to reclassification)











    July 29,

    2023





    January 28,

    2023



    ASSETS













    Current assets:













    Cash and cash equivalents



    $

    173,014





    $

    201,901



    Receivables, less allowance for credit losses1





    66,258







    49,580



    Merchandise inventories, net





    675,441







    652,430



    Prepaid expenses





    54,880







    51,274



    Other current assets





    55,247







    60,809



    Total current assets





    1,024,840







    1,015,994



    Fixed assets





    2,090,367







    1,987,560



    Less accumulated depreciation





    (1,270,141)







    (1,184,233)



    Fixed assets, net





    820,226







    803,327



    Operating lease right-of-use assets





    1,401,834







    1,397,761



    Goodwill





    2,196,664







    2,193,941



    Trade name





    1,025,000







    1,025,000



    Other long-term assets





    193,698







    176,806



    Total assets



    $

    6,662,262





    $

    6,612,829



    LIABILITIES AND EQUITY













    Current liabilities:













    Accounts payable and book overdrafts



    $

    477,748





    $

    381,213



    Accrued salaries and employee benefits





    90,796







    89,929



    Accrued expenses and other liabilities





    219,910







    217,556



    Current portion of operating lease liabilities





    281,415







    309,766



    Current portion of long-term debt and other lease liabilities





    5,077







    22,794



    Total current liabilities





    1,074,946







    1,021,258



    Senior secured credit facilities, net, excluding current portion





    1,588,523







    1,628,331



    Operating lease liabilities, excluding current portion





    1,159,696







    1,148,155



    Deferred taxes, net





    294,094







    303,121



    Other long-term liabilities





    130,239







    130,487



    Total liabilities





    4,247,498







    4,231,352



    Commitments and contingencies













    Stockholders' equity:













    Class A common stock2





    230







    228



    Class B-1 common stock3





    38







    38



    Class B-2 common stock4





    —







    —



    Preferred stock5





    —







    —



    Additional paid-in-capital





    2,196,235







    2,152,342



    Retained earnings





    216,470







    232,967



    Accumulated other comprehensive income (loss)





    1,791







    (4,098)



    Total stockholders' equity





    2,414,764







    2,381,477



    Total liabilities and stockholders' equity



    $

    6,662,262





    $

    6,612,829







    (1)

    Allowances for credit losses are $1,164 and $952, respectively

    (2)

    Class A common stock, $0.001 par value: Authorized - 1.0 billion shares; Issued and outstanding - 229.8 million and 228.3 million shares, respectively

    (3)

    Class B-1 common stock, $0.001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

    (4)

    Class B-2 common stock, $0.000001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

    (5)

    Preferred stock, $0.001 par value: Authorized - 25.0 million shares; Issued and outstanding - none

     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited and subject to reclassification)











    26 Weeks Ended







    July 29,

    2023





    July 30,

    2022



    Cash flows from operating activities:













    Net (loss) income



    $

    (16,498)





    $

    37,258



    Adjustments to reconcile net (loss) income to net cash provided by

      operating activities:













    Depreciation and amortization





    97,919







    95,570



    Amortization of debt discounts and issuance costs





    2,446







    2,456



    Provision for deferred taxes





    (11,002)







    9,216



    Equity-based compensation





    46,248







    25,117



    Impairments, write-offs and losses on sale of fixed and other assets





    1,035







    1,369



    Loss on partial extinguishment of debt





    746







    —



    Amounts reclassified out of accumulated other comprehensive income (loss)





    1,055







    —



    Income from equity method investees





    (6,458)







    (5,194)



    Non-cash operating lease costs





    211,576







    210,946



    Other non-operating (income) loss





    (4,614)







    9,945



    Changes in assets and liabilities:













    Receivables





    (16,679)







    10,856



    Merchandise inventories





    (23,011)







    (48,225)



    Prepaid expenses and other assets





    (14,237)







    (21,932)



    Accounts payable and book overdrafts





    97,062







    12,626



    Accrued salaries and employee benefits





    1,221







    (37,345)



    Accrued expenses and other liabilities





    (1,238)







    5,148



    Operating lease liabilities





    (232,518)







    (205,884)



    Other long-term liabilities





    1,212







    (1,839)



    Net cash provided by operating activities





    134,265







    100,088



    Cash flows from investing activities:













    Cash paid for fixed assets





    (114,023)







    (136,190)



    Cash paid for acquisitions, net of cash acquired





    (2,040)







    (2,888)



    Cash paid for interest in veterinary joint venture





    —







    (35,000)



    Proceeds from investment





    10,248







    —



    Proceeds from sale of assets





    —







    2,127



    Net cash used in investing activities





    (105,815)







    (171,951)



    Cash flows from financing activities:













    Borrowings under long-term debt agreements





    —







    4,000



    Repayments of long-term debt





    (60,000)







    (12,500)



    Payments for finance lease liabilities





    (3,349)







    (2,964)



    Proceeds from employee stock purchase plan and stock option exercises





    2,454







    2,591



    Tax withholdings on stock-based awards





    (4,873)







    (13,461)



    Net cash used in financing activities





    (65,768)







    (22,334)

















    Net decrease in cash, cash equivalents and restricted cash





    (37,318)







    (94,197)



    Cash, cash equivalents and restricted cash at beginning of period





    213,727







    221,890



    Cash, cash equivalents and restricted cash at end of period



    $

    176,409





    $

    127,693



     

    NON-GAAP FINANCIAL MEASURES

    The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release. The non-GAAP financial measures in this earnings release may differ from similarly titled measures used by other companies.

    The tables below reflect the calculation of Adjusted EBITDA (include Trailing Twelve Month Adjusted EBITDA), Adjusted Net Income, Adjusted EPS, and Free Cash Flow, for the thirteen weeks ended July 29, 2023, compared to the thirteen weeks ended July 30, 2022 as well as the twelve-month period ended January 28, 2023.

    Adjusted EBITDA and Trailing Twelve Month Adjusted EBITDA

    Adjusted EBITDA, including Trailing Twelve Month Adjusted EBITDA, is considered a non-GAAP financial measure under the Securities and Exchange Commission's (SEC) rules because it excludes certain amounts included in net income calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be Petco's core operating performance as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period. Please see the company's Annual Report on Form 10-K for the fiscal year ended January 28, 2023 filed with the SEC on March 28, 2023 for additional information on Adjusted EBITDA.













    (dollars in thousands)



    13 Weeks Ended



    Reconciliation of Net (Loss) Income Attributable to Class A and B-1

       Common Stockholders to Adjusted EBITDA



    July 29,

    2023



    July 30,

    2022



    Net (loss) income attributable to Class A and B-1 common stockholders



    $     (14,606)



    $      13,456



    Add (deduct):











    Interest expense, net



    36,729



    21,683



    Income tax expense



    6,732



    6,638



    Depreciation and amortization



    48,664



    48,603



    Income from equity method investees



    (3,328)



    (2,031)



    Loss on partial extinguishment of debt



    305



    —



    Asset impairments and write offs



    1,031



    1,207



    Equity-based compensation



    24,119



    12,895



    Other non-operating (income) loss



    (1,795)



    10,259



    Mexico joint venture EBITDA (1)



    8,544



    6,501



    Acquisition-related integration costs (2)



    —



    10,859



    Other costs (3)



    6,183



    3,427



    Adjusted EBITDA



    $    112,578



    $    133,497



    Net sales



    $ 1,530,734



    $ 1,480,797



    Net margin (4)



    (1.0 %)



    0.9 %



    Adjusted EBITDA Margin



    7.4 %



    9.0 %



     

    (dollars in thousands)



    Trailing Twelve Months



    Reconciliation of Net Income Attributable to Class A and B-1

       Common Stockholders to Adjusted EBITDA



    July 29,

    2023





    January 28,

    2023





    July 30,

    2022



    Net income attributable to Class A and B-1 common stockholders



    $

    36,154





    $

    90,801





    $

    119,895



    Add (deduct):



















    Interest expense, net





    132,068







    100,611







    78,932



    Income tax expense





    24,433







    35,347







    40,422



    Depreciation and amortization





    196,177







    193,828







    185,156



    Income from equity method investees





    (14,240)







    (12,976)







    (11,224)



    Loss on partial extinguishment of debt





    746







    —







    —



    Asset impairments and write offs





    1,658







    1,992







    9,597



    Equity-based compensation





    81,915







    60,784







    51,272



    Other non-operating (income) loss





    (1,892)







    12,667







    20,609



    Mexico joint venture EBITDA (1)





    33,583







    29,584







    28,254



    Acquisition-related integration costs (2)





    2,219







    15,314







    13,095



    Other costs (3)





    8,860







    2,817







    3,448



    Adjusted EBITDA



    $

    501,681





    $

    530,769





    $

    539,456



    Net sales



    $

    6,165,821





    $

    6,035,967





    $

    5,914,409



    Net margin (4)





    0.6

    %





    1.5

    %





    2.0

    %

    Adjusted EBITDA Margin





    8.1

    %





    8.8

    %





    9.1

    %

     

    Adjusted Net Income and Adjusted EPS

    Adjusted Net Income and Adjusted diluted Earnings Per Share attributable to Petco common stockholders (Adjusted EPS) are considered non-GAAP financial measures under the SEC's rules because they exclude certain amounts included in the net income attributable to Petco common stockholders and diluted earnings per share attributable to Petco common stockholders calculated in accordance with GAAP. Management believes that Adjusted Net Income and Adjusted EPS are meaningful measures to share with investors because they facilitate comparison of the current period performance with that of the comparable prior period. In addition, Adjusted Net Income and Adjusted EPS afford investors a view of what management considers to be Petco's core earnings performance as well as the ability to make a more informed assessment of such earnings performance with that of the prior period.

    (in thousands, except per share amounts)



    13 Weeks Ended



    Reconciliation of Diluted EPS to Adjusted EPS



    July 29, 2023





    July 30, 2022







    Amount





    Per share





    Amount





    Per share



    Net (loss) income attributable to common stockholders / diluted EPS



    $

    (14,606)





    $

    (0.05)





    $

    13,456





    $

    0.05



    Add (deduct):

























    Income tax expense





    6,732







    0.02







    6,638







    0.02



    Loss on partial extinguishment of debt





    305







    0.00







    —







    —



    Asset impairments and write offs





    1,031







    0.01







    1,207







    0.01



    Equity-based compensation





    24,119







    0.09







    12,895







    0.05



    Other non-operating (income) loss





    (1,795)







    (0.01)







    10,259







    0.04



    Acquisition-related integration costs (2)





    —







    —







    10,859







    0.04



    Other costs (3)





    6,183







    0.02







    3,427







    0.01



    Adjusted pre-tax income / diluted earnings per share



    $

    21,969





    $

    0.08





    $

    58,741





    $

    0.22



    Income tax expense at 26% normalized tax rate





    5,712







    0.02







    15,273







    0.06



    Adjusted Net Income / Adjusted EPS



    $

    16,257





    $

    0.06





    $

    43,468





    $

    0.16



     

    Free Cash Flow

    Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company's financial performance.













    (in thousands)



    13 Weeks Ended







    July 29,

    2023



    July 30,

    2022



    Net cash provided by operating activities



    $      96,614



    $      42,569



    Cash paid for fixed assets



    (51,973)



    (70,280)



    Free Cash Flow



    $      44,641



    $     (27,711)



     

    Non-GAAP Financial Measures Footnotes

    (1)

    Mexico Joint Venture EBITDA represents 50 percent of the entity's operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company's Mexico joint venture on an Adjusted EBITDA basis to ensure consistency. The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA.









    13 Weeks Ended



    (in thousands)



    July 29,

    2023



    July 30,

    2022



    Net income



    $        6,656



    $        4,064



    Depreciation



    6,443



    4,711



    Income tax expense



    2,364



    2,390



    Foreign currency loss



    395



    444



    Interest expense, net



    1,230



    1,392



    EBITDA



    $      17,088



    $      13,001



    50% of EBITDA



    $        8,544



    $        6,501







    (2)

    Acquisition-related integration costs include direct costs resulting from acquiring and integrating businesses. These include third-party professional and legal fees and other integration-related costs that would not have otherwise been incurred as part of the company's operations.

    (3)

    Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.

    (4)

    We define net margin as net income attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/petco-health--wellness-company-inc-reports-second-quarter-earnings-301908592.html

    SOURCE Petco - Investor Relations

    Get the next $WOOF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WOOF

    DatePrice TargetRatingAnalyst
    7/19/2024$3.00 → $4.00Neutral
    Citigroup
    4/2/2024$5.00 → $1.50Buy → Underperform
    BofA Securities
    12/19/2023$3.11Hold
    Jefferies
    11/30/2023$8.00 → $3.00Outperform → Neutral
    Robert W. Baird
    11/29/2023Overweight → Equal Weight
    Wells Fargo
    9/29/2023Peer Perform
    Wolfe Research
    8/25/2023$10.00 → $7.00Outperform
    RBC Capital Mkts
    4/28/2023$10.00Hold
    Gordon Haskett
    More analyst ratings

    $WOOF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Executive Officer Anderson Joel D

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    2/19/26 6:23:23 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Chief Human Resources Officer May Holly

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    2/19/26 6:22:14 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Chief Revenue Officer Venezia Patrick J

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    2/19/26 6:20:34 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup reiterated coverage on Petco Health and Wellness with a new price target

    Citigroup reiterated coverage of Petco Health and Wellness with a rating of Neutral and set a new price target of $4.00 from $3.00 previously

    7/19/24 8:30:14 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Health and Wellness downgraded by BofA Securities with a new price target

    BofA Securities downgraded Petco Health and Wellness from Buy to Underperform and set a new price target of $1.50 from $5.00 previously

    4/2/24 7:46:18 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Jefferies initiated coverage on Petco Health and Wellness with a new price target

    Jefferies initiated coverage of Petco Health and Wellness with a rating of Hold and set a new price target of $3.11

    12/19/23 6:54:34 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Anderson Joel D bought $4,717,461 worth of shares (1,586,088 units at $2.97) (SEC Form 4)

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    4/1/25 7:14:43 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Breitner Cameron bought $2,354,325 worth of shares (750,000 units at $3.14) (SEC Form 4)

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    5/29/24 7:35:36 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Briggs Gary S bought $99,924 worth of shares (30,000 units at $3.33), increasing direct ownership by 75% to 70,085 units (SEC Form 4)

    4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

    12/4/23 7:29:44 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Petco Announces Completion of Refinancing and Glenn Murphy's Transition to Chairman

    SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced the successful closing of the previously announced long-term debt refinancing and the transition of Glenn Murphy, Executive Chairman of Petco, to Chairman of the Board of Directors, effective February 1. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Joel Anderso

    2/2/26 4:15:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Announces Pricing of its $600,000,000 Offering of Senior Secured Notes

    SAN DIEGO, Jan. 22, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF) today announced the pricing of its previously announced senior secured notes offering and has agreed to issue and sell $600,000,000 in aggregate principal amount of new senior secured notes due on February 1, 2031, which will bear interest at a rate of 8.250% per annum (the "notes").  Completion of the notes offering is expected to occur on February 2, 2026 and is subject to, among other things, customary closing conditions. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco

    1/22/26 6:30:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Announces $650,000,000 Offering of Senior Secured Notes

    SAN DIEGO, Jan. 21, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF) today announced an offering of $650,000,000 in aggregate principal amount of new senior secured notes (the "notes"). Completion of the notes offering is subject to, among other things, pricing and customary closing conditions. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Petco intends to use the net proceeds from the sale of the notes, together with borrowings un

    1/21/26 9:24:00 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    SEC Filings

    View All

    Petco Health and Wellness Company Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

    2/2/26 4:30:27 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Health and Wellness Company Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

    2/2/26 4:05:27 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Health and Wellness Company Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

    1/21/26 9:28:05 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Financials

    Live finance-specific insights

    View All

    Petco Reports Third Quarter 2025 Financial Results

    Upwardly Revises Fiscal 2025 Earnings Outlook* SAN DIEGO, Nov. 25, 2025 /PRNewswire/ -- Petco (NASDAQ:WOOF) today announced its third quarter 2025 financial results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Q3 2025 Overview Net sales of $1.5 billion decreased 3.1% year over year in line with the company's third quarter outlookComparable sales decreased 2.2% year over yearGross profit margin expanded approximately 75 ba

    11/25/25 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco to Host Third Quarter 2025 Earnings Conference Call on Nov. 25, 2025

    SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- Petco (NASDAQ:WOOF), today announced that its financial results for the third quarter fiscal 2025 will be released after market close on Tuesday, Nov. 25, 2025. The company will host a conference call at 4:30 p.m. Eastern time to discuss the results. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> A live webcast of the conference call will be available on the company's Investor Relatio

    11/11/25 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Petco Reports Second Quarter 2025 Financial Results

    Raises Fiscal 2025 Earnings Outlook* SAN DIEGO, Aug. 28, 2025 /PRNewswire/ -- Petco (NASDAQ:WOOF) today announced its second quarter 2025 financial results.  Q2 2025 Overview Net sales of $1.5 billion decreased 2.3% year over year in line with the company's second quarter outlookComparable sales decreased 1.4% year over yearGross profit margin expanded approximately 120 basis points to 39.3% as a percentage of net salesOperating income improved $40.6 million to $43.0 millionGAAP net income improved $38.8 million to $14.0 millionAdjusted EBITDA1 increased $30.3 million to $113.

    8/28/25 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Leadership Updates

    Live Leadership Updates

    View All

    Petco Announces Completion of Refinancing and Glenn Murphy's Transition to Chairman

    SAN DIEGO, Feb. 2, 2026 /PRNewswire/ -- Petco (NASDAQ:WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today announced the successful closing of the previously announced long-term debt refinancing and the transition of Glenn Murphy, Executive Chairman of Petco, to Chairman of the Board of Directors, effective February 1. https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)" alt="Petco Health + Wellness Company, Inc. Logo https://ir.petco.com/ (PRNewsfoto/Petco Health and Wellness Company, Inc.)"> Joel Anderso

    2/2/26 4:15:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    Leslie's Announces Seasoned Retail Executive Amy College as Chief Merchandising and Supply Chain Officer

    PHOENIX, July 15, 2025 (GLOBE NEWSWIRE) -- Leslie's, Inc. (NASDAQ:LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced appointment of Amy College as the company's new Chief Merchandising and Supply Chain Officer effective July 20, 2025. In addition to merchandising, inventory, supply chain, logistics and manufacturing, Ms. College will be responsible for the company's digital marketplace business. In conjunction with Ms. College's appointment, Moyo LaBode, the company's outgoing Chief Merchandising and Supply Chain Officer has left Leslie's, effective July 15, 202

    7/15/25 4:10:43 PM ET
    $LESL
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    PETCO STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF THREE PROVEN EXECUTIVES

    Sabrina Simmons Appointed Chief Financial Officer Michael Romanko Appointed Chief Customer and Product Officer Jack Stout Appointed Chief Merchandising Officer SAN DIEGO, Feb. 18, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), today announced the appointment of three new leaders to Petco's executive team to support accelerated operational improvement and position the business for a faster return to profitable growth. Sabrina Simmons, former Chief Financial Officer at Gap, Inc., has been named Chief Financial Officer, effective February 17.Michael

    2/18/25 4:10:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    $WOOF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Petco Health and Wellness Company Inc. (Amendment)

    SC 13G/A - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

    2/14/24 12:55:28 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form SC 13G/A filed by Petco Health and Wellness Company Inc. (Amendment)

    SC 13G/A - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

    2/14/24 6:00:20 AM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary

    SEC Form SC 13G filed by Petco Health and Wellness Company Inc.

    SC 13G - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

    2/14/22 4:43:20 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary